What is Lemaitre Vascular Inc share price today?

Lemaitre Vascular Inc (LMAT) share price today is {{live_price}}.

Can Indians buy Lemaitre Vascular Inc shares?

Yes, Indians can invest in the Lemaitre Vascular Inc (LMAT) from India. With INDmoney, you can buy Lemaitre Vascular Inc at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Lemaitre Vascular Inc at zero transaction cost.

How can I buy Lemaitre Vascular Inc shares from India?

It is very easy to buy Lemaitre Vascular Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lemaitre Vascular Inc be purchased?

Yes, you can buy fractional shares of Lemaitre Vascular Inc with INDmoney app.

What are the documents required to start investing in Lemaitre Vascular Inc stocks?

To start investing in Lemaitre Vascular Inc, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lemaitre Vascular Inc

Today’s highest price of Lemaitre Vascular Inc (LMAT) is {{1_rba_end}}. Today’s lowest price of Lemaitre Vascular Inc (LMAT) is {{1_rba_st}}.

What is today's market capitalisation of Lemaitre Vascular Inc

Today's market capitalisation of Lemaitre Vascular Inc LMAT is 2.0B

What is the 52 Week High and Low Range of Lemaitre Vascular Inc

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Lemaitre Vascular Inc is down from its 52 Week High?

Lemaitre Vascular Inc (LMAT) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Lemaitre Vascular Inc is up from its 52 Week low?

Lemaitre Vascular Inc (LMAT) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Lemaitre Vascular Inc?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Lemaitre Vascular Inc

Mr. George W. LeMaitre is the current Chief Executive Officer (CEO) of Lemaitre Vascular Inc.

Home>
US Stocks>
Lemaitre Vascular Inc

Lemaitre Vascular Inc (LMAT)

$88.06

-0.03

(-0.03%)▲

Market is closed - opens 7 PM, 09 Sep 2024

Performance

$86.11
$89.50
$88.06
2.22%
Downside
Day's Volatility :3.79%
Upside
1.61%
$44.27
$92.90
$88.06
49.73%
Downside
52 Weeks Volatility :52.35%
Upside
5.21%

Returns

Period	Lemaitre Vascular Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	13.66%	5.1%	0.0%
6 Months	28.29%	4.9%	0.0%
1 Year	54.57%	16.6%	0.0%
3 Years	47.85%	13.2%	-22.3%

Highlights

Market Capitalization	2.0B
Book Value	$14.22
Dividend Share	0.6
Dividend Yield	0.73%
Earnings Per Share (EPS)	1.67
PE Ratio	52.73
PEG Ratio	2.09
Wall Street Target Price	95.75

Profit Margin	18.33%
Operating Margin TTM	25.75%

Return On Assets TTM	8.27%
Return On Equity TTM	12.49%

Revenue TTM	205.6M
Revenue Per Share TTM	9.2
Quarterly Revenue Growth YOY	11.4%
Gross Profit TTM	104.9M
EBITDA	55.2M
Diluted Eps TTM	1.67
Quarterly Earnings Growth YOY	0.44

EPS Estimate Current Year	1.85
EPS Estimate Next Year	2.05
EPS Estimate Current Quarter	0.47
EPS Estimate Next Quarter	0.42

Analyst Recommendation

Buy

73%Buy

26%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Lemaitre Vascular Inc(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 8.73%

Current $88.06

Target $95.75

Company Financials

	FY18	Y/Y Change
Revenue	105.6M	↑ 4.66%
Net Income	22.9M	↑ 33.57%
Net Profit Margin	21.73%	↑ 4.7%

	FY19	Y/Y Change
Revenue	117.2M	↑ 11.05%
Net Income	17.9M	↓ 21.83%
Net Profit Margin	15.3%	↓ 6.43%

	FY20	Y/Y Change
Revenue	129.4M	↑ 10.35%
Net Income	21.2M	↑ 18.32%
Net Profit Margin	16.4%	↑ 1.1%

	FY21	Y/Y Change
Revenue	154.4M	↑ 19.37%
Net Income	26.9M	↑ 26.8%
Net Profit Margin	17.42%	↑ 1.02%

	FY22	Y/Y Change
Revenue	161.7M	↑ 4.68%
Net Income	20.6M	↓ 23.31%
Net Profit Margin	12.77%	↓ 4.65%

	FY23	Y/Y Change
Revenue	193.5M	↑ 19.69%
Net Income	30.1M	↑ 45.89%
Net Profit Margin	15.56%	↑ 2.79%

	Q1 FY23	Q/Q Change
Revenue	47.1M	↑ 14.95%
Net Income	6.0M	↑ 7.34%
Net Profit Margin	12.83%	↓ 0.91%

	Q2 FY23	Q/Q Change
Revenue	50.1M	↑ 6.46%
Net Income	8.1M	↑ 34.07%
Net Profit Margin	16.16%	↑ 3.33%

	Q3 FY23	Q/Q Change
Revenue	47.4M	↓ 5.4%
Net Income	7.5M	↓ 7.36%
Net Profit Margin	15.82%	↓ 0.34%

	Q4 FY23	Q/Q Change
Revenue	48.9M	↑ 3.1%
Net Income	8.5M	↑ 12.84%
Net Profit Margin	17.32%	↑ 1.5%

	Q1 FY24	Q/Q Change
Revenue	53.5M	↑ 9.4%
Net Income	9.9M	↑ 16.8%
Net Profit Margin	18.49%	↑ 1.17%

	Q2 FY24	Q/Q Change
Revenue	55.8M	↑ 4.43%
Net Income	11.8M	↑ 19.61%
Net Profit Margin	21.17%	↑ 2.68%

	FY18	Y/Y Change
Total Assets	153.1M	↑ 21.19%
Total Liabilities	22.9M	↑ 38.06%

	FY19	Y/Y Change
Total Assets	188.3M	↑ 23.03%
Total Liabilities	40.2M	↑ 75.89%

	FY20	Y/Y Change
Total Assets	252.8M	↑ 34.23%
Total Liabilities	80.2M	↑ 99.62%

	FY21	Y/Y Change
Total Assets	292.8M	↑ 15.82%
Total Liabilities	38.7M	↓ 51.83%

	FY22	Y/Y Change
Total Assets	310.5M	↑ 6.04%
Total Liabilities	42.3M	↑ 9.38%

	FY23	Y/Y Change
Total Assets	346.8M	↑ 11.69%
Total Liabilities	48.9M	↑ 15.62%

	Q1 FY23	Q/Q Change
Total Assets	314.9M	↑ 1.41%
Total Liabilities	40.7M	↓ 3.72%

	Q2 FY23	Q/Q Change
Total Assets	326.5M	↑ 3.68%
Total Liabilities	42.6M	↑ 4.76%

	Q3 FY23	Q/Q Change
Total Assets	334.0M	↑ 2.31%
Total Liabilities	45.4M	↑ 6.41%

	Q4 FY23	Q/Q Change
Total Assets	346.8M	↑ 3.82%
Total Liabilities	48.9M	↑ 7.72%

	Q1 FY24	Q/Q Change
Total Assets	354.0M	↑ 2.07%
Total Liabilities	45.5M	↓ 7.01%

	Q2 FY24	Q/Q Change
Total Assets	363.1M	↑ 2.58%
Total Liabilities	43.5M	↓ 4.2%

	FY18	Y/Y Change
Operating Cash Flow	19.5M	↓ 14.7%
Investing Cash Flow	-7.1M	↓ 75.64%
Financing Cash Flow	-4.4M	↓ 5620.0%

	FY19	Y/Y Change
Operating Cash Flow	14.2M	↓ 27.31%
Investing Cash Flow	-24.1M	↑ 241.6%
Financing Cash Flow	-4.6M	↑ 4.66%

	FY20	Y/Y Change
Operating Cash Flow	34.8M	↑ 145.43%
Investing Cash Flow	-52.9M	↑ 119.46%
Financing Cash Flow	32.2M	↓ 795.69%

	FY21	Y/Y Change
Operating Cash Flow	35.1M	↑ 0.87%
Investing Cash Flow	-61.1M	↑ 15.48%
Financing Cash Flow	13.7M	↓ 57.39%

	FY22	Y/Y Change
Operating Cash Flow	25.4M	↓ 27.7%
Investing Cash Flow	-10.4M	↓ 83.02%
Financing Cash Flow	-9.2M	↓ 167.39%

	Q1 FY23	Q/Q Change
Operating Cash Flow	2.3M	↓ 44.1%
Investing Cash Flow	-3.0M	↑ 637.31%
Financing Cash Flow	-1.8M	↓ 14.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	11.9M	↑ 422.29%
Investing Cash Flow	-9.6M	↑ 225.2%
Financing Cash Flow	502.0K	↓ 127.51%

Technicals Summary

Sell

Neutral

Buy

Lemaitre Vascular Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lemaitre Vascular Inc	9.66%	28.29%	54.57%	47.85%	172.21%
Intuitive Surgical, Inc.	5.02%	20.15%	58.74%	31.28%	184.98%
Resmed Inc.	16.09%	27.14%	62.7%	-17.28%	81.24%
Becton, Dickinson And Company	0.02%	-2.08%	-12.88%	-9.76%	-9.75%
West Pharmaceutical Services Inc	1.18%	-17.93%	-26.4%	-35.64%	104.36%
Alcon Ag	3.83%	8.9%	15.02%	11.44%	61.54%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lemaitre Vascular Inc	52.73	52.73	2.09	1.85	0.12	0.08	0.01	14.22
Intuitive Surgical, Inc.	81.91	81.91	4.06	6.65	0.16	0.08	NA	41.4
Resmed Inc.	35.33	35.33	2.05	7.71	0.23	0.13	0.01	33.11
Becton, Dickinson And Company	46.72	46.72	1.08	13.11	0.06	0.03	0.02	89.5
West Pharmaceutical Services Inc	42.71	42.71	5.15	6.51	0.2	0.11	0.0	35.49
Alcon Ag	42.64	42.64	3.53	3.05	0.05	0.03	0.0	42.35

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lemaitre Vascular Inc	Buy	$2.0B	172.21%	52.73	18.33%
Intuitive Surgical, Inc.	Buy	$169.4B	184.98%	81.91	27.65%
Resmed Inc.	Buy	$36.0B	81.24%	35.33	21.79%
Becton, Dickinson And Company	Buy	$67.4B	-9.75%	46.72	7.13%
West Pharmaceutical Services Inc	Buy	$21.8B	104.36%	42.71	18.25%
Alcon Ag	Buy	$46.7B	61.54%	42.64	11.44%

Insights on Lemaitre Vascular Inc

Increasing Revenue
Revenue is up for the last 4 quarters, 47.41M → 55.84M (in $), with an average increase of 5.3% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, 7.50M → 11.82M (in $), with an average increase of 14.1% per quarter
Vs RMD
In the last 1 year, Resmed Inc. has given 62.7% return, outperforming this stock by 8.1%